Status:
COMPLETED
Brain Fog and Life Quality in Menopause
Lead Sponsor:
Merve Coskun
Conditions:
Menopause
Cognitive Dysfunction
Eligibility:
FEMALE
40-60 years
Brief Summary
This clinical study aims to investigate cognitive changes in women undergoing the menopausal transition, with a specific focus on the prevalence, characteristics, and impact of brain fog. The research...
Detailed Description
Menopause is a natural biological process characterized by a decline in ovarian function and a marked reduction in estrogen and progesterone levels, often accompanied by elevated follicle-stimulating ...
Eligibility Criteria
Inclusion
- Aged between 40 and 60 years.
- In any stage of menopause.
- Able to complete the Brain Fog Scale and Menopause-Specific Quality of Life Scale due to cognitive and physical capability.
- Willing to participate in the study voluntarily.
- Able to read and write in Turkish.
Exclusion
- Diagnosed with neurological or psychiatric disorders (e.g., Alzheimer's, Dementia, Schizophrenia, etc.).
- Currently receiving hormone therapy.
- Experiencing menstrual irregularities due to reasons other than menopause.
- Unable to complete the scales due to visual impairment or significant cognitive limitations.
Key Trial Info
Start Date :
May 8 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 16 2025
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT06978218
Start Date
May 8 2025
End Date
July 16 2025
Last Update
August 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Merve Coşkun
Ataşehir, Istanbul, Turkey (Türkiye)